Trial to assess chelation therapy 2- TACT2 CCC

Ended Cooperative Agreement Awarded Last action

Award ID
UH3AT009149
Recipient
Awarding agency
Obligated
$17,730,528

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding agency
National Heart Lung and Blood Institute National Institutes of Health, Department of Health and Human Services
Place of performance
Miami Beach, FL 33140, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$906
Amendment $0
Amendment $0
Amendment $0
Amendment $22,036
Amendment $893,466
Amendment Trial to assess chelation therapy 2- TACT2 CCC - description (provided by applicant): the purpose of the trial to assess chelation therapy 2 (TACT2) is to… $1,153,749
Amendment $228,972
Amendment $665,051
Amendment $250,000
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $823,477
Amendment $2,642,477
Amendment $250,000
Amendment $2,027,925
Amendment $333,598
Amendment $25,000
Amendment $1,756,941
Amendment $1,245,450
Amendment $225,000
Amendment $62,815
Amendment $250,638
Amendment $624,839
Amendment $250,000
Original award $4,000,000
Show all 30

Quick answers

Who received award UH3AT009149?

UH3AT009149 was awarded to Mount Sinai Medical Center Of Florida Inc. by National Center for Complementary and Integrative Health (National Institutes of Health) on September 23, 2016.

How much is award UH3AT009149 worth?

$17,730,528 has been obligated on UH3AT009149.

Which agency awarded UH3AT009149?

National Center for Complementary and Integrative Health (National Institutes of Health) awarded UH3AT009149, with funding from National Heart Lung and Blood Institute (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award